RecruitingNot ApplicableNCT04158843

Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

A Randomized, Open Label Trial to Evaluate Radical Local Treatment Versus Palliative Treatment for Breast Cancer Patients With Ipsilateral Humerus or Sternum Oligometastasis


Sponsor

xuexin he

Enrollment

183 participants

Start Date

May 9, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two treatment approaches for women with breast cancer that has spread (metastasized) only to the bone in the shoulder (humerus) or breastbone (sternum) — a situation called oligometastasis (very limited spread). One approach is radical local treatment (aggressive targeted therapy to the metastatic site) versus standard palliative therapy. The goal is to see if aggressively treating the single metastatic site improves survival. **You may be eligible if...** - You are a woman between 18 and 75 years old - You have histologically confirmed breast cancer and have had a mastectomy - Your cancer has spread only to the ipsilateral (same-side) humerus or sternum, with no other metastases visible on imaging - Your blood counts and organ function meet acceptable thresholds - You do not have HIV **You may NOT be eligible if...** - There is evidence of cancer spread to any other location - You have not recovered from side effects of previous treatments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadical resection

Radical resection is performed, and the cutting edge is negative.

RADIATIONRadical radiotherapy

Radical local radiotherapy is feasible (cumulative radiotherapy dose is greater than or equal to 50Gy).

OTHERPalliative treatment

Including palliative internal fixation, radiotherapy, systemic chemotherapy, endocrine therapy or targeted therapy


Locations(4)

Institute of Cancer Research and Basic Medical Sciences, CAS Cancer Hospital, University of Chinese Academy of Sciences Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China

The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU)

Hangzhou, Zhejiang, China

Jiaxing Second Hospital

Jiaxing, Zhejiang, China

The Central Hospital of Lishui

Lishui, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04158843


Related Trials